New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—

Psyence Biomedical Ltd. (PBM) P/E ratio

Alert me on P/E ratio

As of Nov 20, 2026, Psyence Biomedical Ltd. (PBM) trades at a P/E ratio of 0.1×. Over the past ten years it has ranged from 0.0× (September 2024) to 2,929,688× (September 2023); the current reading is higher than 25% of that period. That is below the Biotechnology industry median of 8.5× and below the Healthcare sector median of 21.7×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change

Against its own ten years

Low 0.0× High 2,929,688×
Ten-year median 1.1×
Current reading's percentile 6

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PBM